Tyme technologies inc

Major-Pharmaceuticals

TYME


17 State Street
New York , NY 10004

Executive/
Director

Links

Price

  • Last Close
  • $ 0.31
    $ +0.04 12.68 %
    Sep 16, 2022
  • 52-Week High/Low
  • $0 - $0
  • YTD
  • 0%

  • Trading Volume
  • 2,597,928
  • Market Cap Full
  • $ 53.4M
  • Shares Outstanding
  • 172.2M
    Aug 4, 2022
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Q1 - - -65.1% -52.3% -5% 46.7% -42% - - -
Q2 - - 43.6% -41.6% 4% -29.6% -20% - - -
Q3 - 24.2% -16.3% 19.3% 8% -18.3% 11.1% - - -
Q4 - 8.1% 36.2% -0.7% 24.5% -41.5% - - - -
J F M A M J J A S O N D
2025 - - - - - - - - - - - -
2024 - - - - - - - - - - - -
    2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
    0%0%0%-42%-62%-13%-51%-48%0%0%0%

Earnings

2016 2017 2018 2019 2020 2021
Q1 - - -0.06 -0.1 -0.05 -0.05
Q2 - 0.03 -0.07 -0.03 -0.07 -0.03
Q3 - 0.06 -0.07 -0.05 -0.05 -0.03
Q4 - - -0.08 -0.06 -0.05 -0.03
A 0 0.1 -0.3 -0.2 -0.2 -0.1

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2018 2019 2020 2021 2022
Mar - 103.3 122.8 130.4 172.2
Jun - 112 123.3 172.2 172.2
Sep 101.2 112 126.9 172.2 172.2
Dec 103 112 130.2 172.2 -

Financial Ratios

20212020201920182017
Asset Management
Inventory / Stock Turnover - - - - -
Fixed Asset Turnover - - - - -
Total Asset Turnover - - - - -
Leverage
Debt Ratio - - - - -
Debt – Equity Ratio - - - - -
Interest Coverage -15.5 6.9 -26.3 49.6 -
Equity multiplier - 0.1 0.1 - -